Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
|
|
|
19.
|
A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. [electronic resource] by
- Vincenti, F
- Mendez, R
- Pescovitz, M
- Rajagopalan, P R
- Wilkinson, A H
- Butt, K
- Laskow, D
- Slakey, D P
- Lorber, M I
- Garg, J P
- Garovoy, M
Producer: 20070808
In:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons vol. 7
Availability: No items available.
|
|
|
20.
|
|